Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.
Barbanoj MJ, Ballester MR, Antonijoan RM, Puntes M, Gropper S, Santos B, Albet C, Guglietta A. Barbanoj MJ, et al. Among authors: puntes m. Clin Exp Pharmacol Physiol. 2009 May;36(5-6):469-77. doi: 10.1111/j.1440-1681.2008.05089.x. Epub 2008 Oct 8. Clin Exp Pharmacol Physiol. 2009. PMID: 19673928 Clinical Trial.
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Ballester MR, Roig E, Gich I, Puntes M, Delgadillo J, Santos B, Antonijoan RM. Ballester MR, et al. Among authors: puntes m. Drug Des Devel Ther. 2015 Aug 5;9:4291-302. doi: 10.2147/DDDT.S86300. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273191 Free PMC article. Clinical Trial.
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
Antonijoan RM, Ferrero-Cafiero JM, Coimbra J, Puntes M, Martínez-Colomer J, Arévalo MI, Mascaró C, Molinero C, Buesa C, Maes T. Antonijoan RM, et al. Among authors: puntes m. CNS Drugs. 2021 Mar;35(3):331-344. doi: 10.1007/s40263-021-00797-x. Epub 2021 Mar 23. CNS Drugs. 2021. PMID: 33755924 Free PMC article. Clinical Trial.
Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial.
Coimbra J, Puntes M, Molina P, Gich I, Antonijoan R, Gilaberte I, Arranz P, Sánchez C. Coimbra J, et al. Among authors: puntes m. Eur J Pharm Sci. 2024 Dec 1;203:106900. doi: 10.1016/j.ejps.2024.106900. Epub 2024 Sep 10. Eur J Pharm Sci. 2024. PMID: 39265704 Free article. Clinical Trial.
18 results